Endologix, Inc. (ELGX) Reports Q2 EPS Loss of $0.09, Revenue up 22% Y/Y, Reaffirms FY11 Guidance

Endologix, Inc. (NASDAQ: ELGX) reported Q2 EPS of ($0.09), $0.02 worse than the analyst estimate of ($0.07). Revenue for the quarter came in at $19.2 million versus the consensus estimate of $19.28 million.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Blackhawk Network (HAWK) Reports Q2 Loss of $0.07; Offers Guidance
• Tenon Medical (TNON) Misses Q2 EPS by 395c
• Laird Superfood, Inc. (LSF) Misses Q2 EPS by 22c ; Offers Guidance